Chao Zhang1, Bruno Balbo1, Ming Ma2, Jun Zhao3,4, Xin Tian1, Yuval Kluger3,4,5, Stefan Somlo2,6. 1. Department of Internal Medicine, Yale University, New Haven, Connecticut. 2. Department of Internal Medicine, Yale University, New Haven, Connecticut stefan.somlo@yale.edu. 3. Department of Pathology, Yale University, New Haven, Connecticut. 4. Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut. 5. Program in Applied Mathematics, Yale University, New Haven, Connecticut. 6. Department of Genetics, Yale University, New Haven, Connecticut.
Abstract
BACKGROUND: Mutations in PKD1 and PKD2, which encode the transmembrane proteins polycystin-1 and polycystin-2, respectively, cause autosomal dominant polycystic kidney disease (ADPKD). Polycystins are expressed in the primary cilium, and disrupting cilia structure significantly slows ADPKD progression following inactivation of polycystins. The cellular mechanisms of polycystin- and cilia-dependent cyst progression in ADPKD remain incompletely understood. METHODS: Unbiased transcriptional profiling in an adult-onset Pkd2 mouse model before cysts formed revealed significant differentially expressed genes (DEGs) in Pkd2 single-knockout kidneys, which were used to identify candidate pathways dysregulated in kidneys destined to form cysts. In vivo studies validated the role of the candidate pathway in the progression of ADPKD. Wild-type and Pkd2/Ift88 double-knockout mice that are protected from cyst growth served as controls. RESULTS: The RNASeq data identified cell proliferation as the most dysregulated pathway, with 15 of 241 DEGs related to cell cycle functions. Cdk1 appeared as a central component in this analysis. Cdk1 expression was similarly dysregulated in Pkd1 models of ADPKD, and conditional inactivation of Cdk1 with Pkd1 markedly improved the cystic phenotype and kidney function compared with inactivation of Pkd1 alone. The Pkd1/Cdk1 double knockout blocked cyst cell proliferation that otherwise accompanied Pkd1 inactivation alone. CONCLUSIONS: Dysregulation of Cdk1 is an early driver of cyst cell proliferation in ADPKD due to Pkd1 inactivation. Selective targeting of cyst cell proliferation is an effective means of slowing ADPKD progression caused by inactivation of Pkd1.
BACKGROUND: Mutations in PKD1 and PKD2, which encode the transmembrane proteins polycystin-1 and polycystin-2, respectively, cause autosomal dominant polycystic kidney disease (ADPKD). Polycystins are expressed in the primary cilium, and disrupting cilia structure significantly slows ADPKD progression following inactivation of polycystins. The cellular mechanisms of polycystin- and cilia-dependent cyst progression in ADPKD remain incompletely understood. METHODS: Unbiased transcriptional profiling in an adult-onset Pkd2 mouse model before cysts formed revealed significant differentially expressed genes (DEGs) in Pkd2 single-knockout kidneys, which were used to identify candidate pathways dysregulated in kidneys destined to form cysts. In vivo studies validated the role of the candidate pathway in the progression of ADPKD. Wild-type and Pkd2/Ift88 double-knockout mice that are protected from cyst growth served as controls. RESULTS: The RNASeq data identified cell proliferation as the most dysregulated pathway, with 15 of 241 DEGs related to cell cycle functions. Cdk1 appeared as a central component in this analysis. Cdk1 expression was similarly dysregulated in Pkd1 models of ADPKD, and conditional inactivation of Cdk1 with Pkd1 markedly improved the cystic phenotype and kidney function compared with inactivation of Pkd1 alone. The Pkd1/Cdk1 double knockout blocked cyst cell proliferation that otherwise accompanied Pkd1 inactivation alone. CONCLUSIONS: Dysregulation of Cdk1 is an early driver of cyst cell proliferation in ADPKD due to Pkd1 inactivation. Selective targeting of cyst cell proliferation is an effective means of slowing ADPKD progression caused by inactivation of Pkd1.
Authors: Ming Yang Chang; Emma Parker; Salwa Ibrahim; John R Shortland; Meguid El Nahas; John L Haylor; Albert C M Ong Journal: Nephrol Dial Transplant Date: 2006-05-23 Impact factor: 5.992
Authors: Xi Chen; Gerd A Müller; Marianne Quaas; Martin Fischer; Namshik Han; Benjamin Stutchbury; Andrew D Sharrocks; Kurt Engeland Journal: Mol Cell Biol Date: 2012-10-29 Impact factor: 4.272
Authors: G Wu; V D'Agati; Y Cai; G Markowitz; J H Park; D M Reynolds; Y Maeda; T C Le; H Hou; R Kucherlapati; W Edelmann; S Somlo Journal: Cell Date: 1998-04-17 Impact factor: 41.582
Authors: Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres Journal: Nat Rev Dis Primers Date: 2018-12-06 Impact factor: 52.329
Authors: James R Davenport; Amanda J Watts; Venus C Roper; Mandy J Croyle; Thomas van Groen; J Michael Wyss; Tim R Nagy; Robert A Kesterson; Bradley K Yoder Journal: Curr Biol Date: 2007-09-06 Impact factor: 10.834
Authors: Chunyan Hu; Katherine Beebe; Edgar J Hernandez; Jose M Lazaro-Guevara; Monica P Revelo; Yufeng Huang; J Alan Maschek; James E Cox; Donald E Kohan Journal: Am J Physiol Renal Physiol Date: 2021-12-20